LinkedIn Profile

Access Concert Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:cnce 73234 Apr 21st, 2024 12:00AM Concert Pharmaceuticals, Inc. 5.6K 38.00 Open Apr 20th, 2024 11:14PM Apr 20th, 2024 11:14PM Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates Open Open 65 Hayden Avenue Lexington MA US 02421 Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce 73234 Apr 20th, 2024 12:00AM Concert Pharmaceuticals, Inc. 5.6K 38.00 Open Apr 19th, 2024 11:11PM Apr 20th, 2024 04:47PM Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates Open Open 65 Hayden Avenue Lexington MA US 02421 Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce 73234 Apr 19th, 2024 12:00AM Concert Pharmaceuticals, Inc. 5.6K 38.00 Open Apr 18th, 2024 11:18PM Apr 18th, 2024 11:18PM Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates Open Open 65 Hayden Avenue Lexington MA US 02421 Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce 73234 Apr 18th, 2024 12:00AM Concert Pharmaceuticals, Inc. 5.6K 38.00 Open Apr 17th, 2024 11:18PM Apr 18th, 2024 06:07PM Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates Open Open 65 Hayden Avenue Lexington MA US 02421 Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce 73234 Apr 17th, 2024 12:00AM Concert Pharmaceuticals, Inc. 5.6K 38.00 Open Apr 16th, 2024 11:08PM Apr 17th, 2024 02:31PM Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates Open Open 65 Hayden Avenue Lexington MA US 02421 Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce 73234 Apr 16th, 2024 12:00AM Concert Pharmaceuticals, Inc. 5.6K 38.00 Open Apr 15th, 2024 11:03PM Apr 16th, 2024 10:47AM Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates Open Open 65 Hayden Avenue Lexington MA US 02421 Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce 73234 Apr 15th, 2024 12:00AM Concert Pharmaceuticals, Inc. 5.6K 38.00 Open Apr 14th, 2024 11:00PM Apr 15th, 2024 04:29PM Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates Open Open 65 Hayden Avenue Lexington MA US 02421 Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce 73234 Apr 14th, 2024 12:00AM Concert Pharmaceuticals, Inc. 5.6K 38.00 Open Apr 13th, 2024 10:49PM Apr 13th, 2024 10:49PM Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates Open Open 65 Hayden Avenue Lexington MA US 02421 Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce 73234 Apr 13th, 2024 12:00AM Concert Pharmaceuticals, Inc. 5.6K 38.00 Open Apr 12th, 2024 10:40PM Apr 13th, 2024 11:15AM Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates Open Open 65 Hayden Avenue Lexington MA US 02421 Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce 73234 Apr 12th, 2024 12:00AM Concert Pharmaceuticals, Inc. 5.6K 38.00 Open Apr 11th, 2024 10:44PM Apr 12th, 2024 08:10AM Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates Open Open 65 Hayden Avenue Lexington MA US 02421 Concert Pharmaceuticals Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.